永安药业：公司股价短期涨幅已严重偏离大盘走势，存在较高的炒作风险
永安药业提醒投资者，公司股价近期涨幅过大，已偏离大盘走势，存在炒作风险。公司基本面无重大变化，2025年一季度处于亏损状态，估值水平高于行业平均水平，建议投资者理性决策、谨慎投资。
媒体报道
永安药业：公司股价短期涨幅较大已严重偏离大盘走势 存在较高的炒作风险 财联社/36Kr
永安药业：公司股价短期涨幅已严重偏离大盘走势，存在较高的炒作风险 钛媒体/界面
#热门话题
BY Readhub
That growth environment will include rising inflation and interest rates. Those upward shifts naturally accompany healthy growth periods as the demand for resources, products and services rise. Importantly, the Federal Reserve has laid out the rationale for not interfering with that natural growth transition.It's not exactly a fad, but there is a widespread willingness to pay up for a growth story. Classic fundamental analysis takes a back seat. Even negative earnings are ignored. In fact, positive earnings seem to be a limiting measure, producing the question, "Is that all you've got?" The preference is a vision of untold riches when the exciting story plays out as expected.
Readhub from us